nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0412	0.146	CbGbCtD
Fulvestrant—CYP3A4—Dapsone—systemic lupus erythematosus	0.036	0.128	CbGbCtD
Fulvestrant—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0312	0.111	CbGbCtD
Fulvestrant—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0312	0.111	CbGbCtD
Fulvestrant—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0268	0.0949	CbGbCtD
Fulvestrant—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0264	0.0937	CbGbCtD
Fulvestrant—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0251	0.0888	CbGbCtD
Fulvestrant—CYP3A4—Prednisone—systemic lupus erythematosus	0.025	0.0885	CbGbCtD
Fulvestrant—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0237	0.0839	CbGbCtD
Fulvestrant—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0156	0.0552	CbGbCtD
Fulvestrant—NR1H4—connective tissue—systemic lupus erythematosus	0.00955	0.0652	CbGeAlD
Fulvestrant—NR1H4—nephron tubule—systemic lupus erythematosus	0.00925	0.0632	CbGeAlD
Fulvestrant—NR1H4—kidney—systemic lupus erythematosus	0.00813	0.0555	CbGeAlD
Fulvestrant—EPHX2—nephron tubule—systemic lupus erythematosus	0.00808	0.0552	CbGeAlD
Fulvestrant—NR1H4—cortex of kidney—systemic lupus erythematosus	0.00791	0.0541	CbGeAlD
Fulvestrant—ESRRA—nephron tubule—systemic lupus erythematosus	0.00708	0.0484	CbGeAlD
Fulvestrant—EPHX2—cortex of kidney—systemic lupus erythematosus	0.00692	0.0473	CbGeAlD
Fulvestrant—ESRRA—kidney—systemic lupus erythematosus	0.00622	0.0425	CbGeAlD
Fulvestrant—ESRRA—cortex of kidney—systemic lupus erythematosus	0.00606	0.0414	CbGeAlD
Fulvestrant—CYP3A4—urine—systemic lupus erythematosus	0.00603	0.0412	CbGeAlD
Fulvestrant—EPHX2—tendon—systemic lupus erythematosus	0.00574	0.0392	CbGeAlD
Fulvestrant—EPHX2—lung—systemic lupus erythematosus	0.00503	0.0344	CbGeAlD
Fulvestrant—ESRRA—tendon—systemic lupus erythematosus	0.00502	0.0343	CbGeAlD
Fulvestrant—ESRRA—bone marrow—systemic lupus erythematosus	0.00487	0.0332	CbGeAlD
Fulvestrant—ESRRA—lung—systemic lupus erythematosus	0.00441	0.0301	CbGeAlD
Fulvestrant—ESR2—connective tissue—systemic lupus erythematosus	0.00439	0.03	CbGeAlD
Fulvestrant—ESRRA—nervous system—systemic lupus erythematosus	0.00408	0.0279	CbGeAlD
Fulvestrant—ESRRA—central nervous system—systemic lupus erythematosus	0.00393	0.0268	CbGeAlD
Fulvestrant—ESR2—kidney—systemic lupus erythematosus	0.00373	0.0255	CbGeAlD
Fulvestrant—ESR2—lymphoid tissue—systemic lupus erythematosus	0.00321	0.0219	CbGeAlD
Fulvestrant—CYP3A4—blood plasma—systemic lupus erythematosus	0.00315	0.0215	CbGeAlD
Fulvestrant—ESR1—connective tissue—systemic lupus erythematosus	0.003	0.0205	CbGeAlD
Fulvestrant—ESR2—lung—systemic lupus erythematosus	0.00265	0.0181	CbGeAlD
Fulvestrant—ESR1—kidney—systemic lupus erythematosus	0.00256	0.0175	CbGeAlD
Fulvestrant—ESR2—nervous system—systemic lupus erythematosus	0.00245	0.0167	CbGeAlD
Fulvestrant—ESR2—central nervous system—systemic lupus erythematosus	0.00236	0.0161	CbGeAlD
Fulvestrant—ESR1—lymphoid tissue—systemic lupus erythematosus	0.0022	0.015	CbGeAlD
Fulvestrant—ESR1—lung—systemic lupus erythematosus	0.00181	0.0124	CbGeAlD
Fulvestrant—ESR1—nervous system—systemic lupus erythematosus	0.00168	0.0115	CbGeAlD
Fulvestrant—ESR1—central nervous system—systemic lupus erythematosus	0.00162	0.011	CbGeAlD
Fulvestrant—CYP3A4—kidney—systemic lupus erythematosus	0.00143	0.00975	CbGeAlD
Fulvestrant—CYP3A4—nervous system—systemic lupus erythematosus	0.000936	0.0064	CbGeAlD
Fulvestrant—CYP3A4—central nervous system—systemic lupus erythematosus	0.000901	0.00616	CbGeAlD
Fulvestrant—ESR1—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000857	0.00417	CbGpPWpGaD
Fulvestrant—ESR1—Signaling events mediated by HDAC Class II—NR3C1—systemic lupus erythematosus	0.000857	0.00417	CbGpPWpGaD
Fulvestrant—ESR2—Plasma membrane estrogen receptor signaling—MMP9—systemic lupus erythematosus	0.000855	0.00416	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—JUNB—systemic lupus erythematosus	0.000844	0.0041	CbGpPWpGaD
Fulvestrant—ESR1—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000831	0.00404	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	0.000829	0.00403	CbGpPWpGaD
Fulvestrant—ESR1—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000752	0.00366	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—IL1RN—systemic lupus erythematosus	0.000751	0.00365	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000739	0.0036	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—JUNB—systemic lupus erythematosus	0.000736	0.00358	CbGpPWpGaD
Fulvestrant—ESR1—Validated nuclear estrogen receptor alpha network—PRL—systemic lupus erythematosus	0.000728	0.00354	CbGpPWpGaD
Fulvestrant—NR1H4—Biological oxidations—RXRA—systemic lupus erythematosus	0.000715	0.00348	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000693	0.00337	CbGpPWpGaD
Fulvestrant—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	0.00069	0.00335	CbGpPWpGaD
Fulvestrant—ESR1—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000677	0.00329	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—MTA2—systemic lupus erythematosus	0.000669	0.00325	CbGpPWpGaD
Fulvestrant—ESR1—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000664	0.00323	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	0.000654	0.00318	CbGpPWpGaD
Fulvestrant—NR1H4—PPARA activates gene expression—PPARG—systemic lupus erythematosus	0.000646	0.00314	CbGpPWpGaD
Fulvestrant—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	0.000632	0.00307	CbGpPWpGaD
Fulvestrant—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000597	0.0029	CbGpPWpGaD
Fulvestrant—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	0.000596	0.0029	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	0.000594	0.00289	CbGpPWpGaD
Fulvestrant—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000591	0.00287	CbGpPWpGaD
Fulvestrant—ESRRA—PPARA activates gene expression—EP300—systemic lupus erythematosus	0.000578	0.00281	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	0.000573	0.00279	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL10—systemic lupus erythematosus	0.000568	0.00276	CbGpPWpGaD
Fulvestrant—ESR2—Validated nuclear estrogen receptor alpha network—EP300—systemic lupus erythematosus	0.000568	0.00276	CbGpPWpGaD
Fulvestrant—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	0.000566	0.00275	CbGpPWpGaD
Fulvestrant—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—systemic lupus erythematosus	0.000558	0.00271	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL4—systemic lupus erythematosus	0.000553	0.00269	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	0.000549	0.00267	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SNRPD1—systemic lupus erythematosus	0.00054	0.00263	CbGpPWpGaD
Fulvestrant—ESR1—Validated nuclear estrogen receptor alpha network—C3—systemic lupus erythematosus	0.000539	0.00262	CbGpPWpGaD
Fulvestrant—ESR1—Plasma membrane estrogen receptor signaling—NOS3—systemic lupus erythematosus	0.000537	0.00261	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—NR3C1—systemic lupus erythematosus	0.000526	0.00256	CbGpPWpGaD
Fulvestrant—ESR1—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000525	0.00255	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—systemic lupus erythematosus	0.00052	0.00253	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—JAK1—systemic lupus erythematosus	0.000513	0.00249	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.00051	0.00248	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—systemic lupus erythematosus	0.000506	0.00246	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—MTA2—systemic lupus erythematosus	0.000489	0.00238	CbGpPWpGaD
Fulvestrant—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000487	0.00133	CcSEcCtD
Fulvestrant—Angiopathy—Prednisone—systemic lupus erythematosus	0.000485	0.00133	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000484	0.00132	CcSEcCtD
Fulvestrant—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000483	0.00132	CcSEcCtD
Fulvestrant—Vertigo—Betamethasone—systemic lupus erythematosus	0.00048	0.00131	CcSEcCtD
Fulvestrant—Vertigo—Dexamethasone—systemic lupus erythematosus	0.00048	0.00131	CcSEcCtD
Fulvestrant—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000479	0.00131	CcSEcCtD
Fulvestrant—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000479	0.00131	CcSEcCtD
Fulvestrant—Infection—Triamcinolone—systemic lupus erythematosus	0.000477	0.00131	CcSEcCtD
Fulvestrant—Sweating—Methotrexate—systemic lupus erythematosus	0.000477	0.0013	CcSEcCtD
Fulvestrant—Infection—Methylprednisolone—systemic lupus erythematosus	0.000476	0.0013	CcSEcCtD
Fulvestrant—Vomiting—Leflunomide—systemic lupus erythematosus	0.000473	0.00129	CcSEcCtD
Fulvestrant—Insomnia—Prednisolone—systemic lupus erythematosus	0.000473	0.00129	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000471	0.00129	CcSEcCtD
Fulvestrant—ESR2—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000471	0.00229	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	0.00047	0.00229	CbGpPWpGaD
Fulvestrant—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.00047	0.00129	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.00047	0.00128	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	0.000469	0.00228	CbGpPWpGaD
Fulvestrant—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000469	0.00128	CcSEcCtD
Fulvestrant—Rash—Leflunomide—systemic lupus erythematosus	0.000469	0.00128	CcSEcCtD
Fulvestrant—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000469	0.00128	CcSEcCtD
Fulvestrant—Nausea—Azathioprine—systemic lupus erythematosus	0.000468	0.00128	CcSEcCtD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—systemic lupus erythematosus	0.000468	0.00227	CbGpPWpGaD
Fulvestrant—Headache—Leflunomide—systemic lupus erythematosus	0.000466	0.00127	CcSEcCtD
Fulvestrant—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000466	0.00127	CcSEcCtD
Fulvestrant—Malnutrition—Prednisone—systemic lupus erythematosus	0.000465	0.00127	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000465	0.00127	CcSEcCtD
Fulvestrant—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000465	0.00127	CcSEcCtD
Fulvestrant—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000464	0.00127	CcSEcCtD
Fulvestrant—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000462	0.00126	CcSEcCtD
Fulvestrant—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000458	0.00125	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000458	0.00125	CcSEcCtD
Fulvestrant—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000456	0.00125	CcSEcCtD
Fulvestrant—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000455	0.00124	CcSEcCtD
Fulvestrant—Myalgia—Betamethasone—systemic lupus erythematosus	0.000455	0.00124	CcSEcCtD
Fulvestrant—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000454	0.00124	CcSEcCtD
Fulvestrant—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000454	0.00124	CcSEcCtD
Fulvestrant—Anxiety—Betamethasone—systemic lupus erythematosus	0.000453	0.00124	CcSEcCtD
Fulvestrant—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000453	0.00124	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	0.000453	0.0022	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—TNFSF13—systemic lupus erythematosus	0.000452	0.0022	CbGpPWpGaD
Fulvestrant—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000449	0.00123	CcSEcCtD
Fulvestrant—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000449	0.00123	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	0.000448	0.00218	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	0.000447	0.00217	CbGpPWpGaD
Fulvestrant—Pain—Prednisolone—systemic lupus erythematosus	0.000447	0.00122	CcSEcCtD
Fulvestrant—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000447	0.00122	CcSEcCtD
Fulvestrant—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000447	0.00122	CcSEcCtD
Fulvestrant—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000445	0.00122	CcSEcCtD
Fulvestrant—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000444	0.00121	CcSEcCtD
Fulvestrant—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000443	0.00121	CcSEcCtD
Fulvestrant—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000443	0.00121	CcSEcCtD
Fulvestrant—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000443	0.00121	CcSEcCtD
Fulvestrant—Nausea—Leflunomide—systemic lupus erythematosus	0.000442	0.00121	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000441	0.0012	CcSEcCtD
Fulvestrant—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.00044	0.0012	CcSEcCtD
Fulvestrant—ESR1—FOXA1 transcription factor network—CDKN1B—systemic lupus erythematosus	0.00044	0.00214	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000438	0.0012	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—SNRPB—systemic lupus erythematosus	0.000437	0.00213	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000437	0.00119	CcSEcCtD
Fulvestrant—Pain—Hydrocortisone—systemic lupus erythematosus	0.000436	0.00119	CcSEcCtD
Fulvestrant—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	0.000436	0.00212	CbGpPWpGaD
Fulvestrant—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000435	0.00119	CcSEcCtD
Fulvestrant—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000434	0.00119	CcSEcCtD
Fulvestrant—Infection—Betamethasone—systemic lupus erythematosus	0.000433	0.00118	CcSEcCtD
Fulvestrant—Infection—Dexamethasone—systemic lupus erythematosus	0.000433	0.00118	CcSEcCtD
Fulvestrant—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000432	0.00118	CcSEcCtD
Fulvestrant—ESR1—Plasma membrane estrogen receptor signaling—MMP9—systemic lupus erythematosus	0.000431	0.0021	CbGpPWpGaD
Fulvestrant—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000431	0.00118	CcSEcCtD
Fulvestrant—Anaemia—Prednisone—systemic lupus erythematosus	0.00043	0.00118	CcSEcCtD
Fulvestrant—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000428	0.00117	CcSEcCtD
Fulvestrant—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000428	0.00117	CcSEcCtD
Fulvestrant—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000428	0.00117	CcSEcCtD
Fulvestrant—ESR2—Gene Expression—MTA2—systemic lupus erythematosus	0.000426	0.00207	CbGpPWpGaD
Fulvestrant—Angioedema—Prednisone—systemic lupus erythematosus	0.000425	0.00116	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	0.000424	0.00206	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000423	0.00116	CcSEcCtD
Fulvestrant—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000423	0.00116	CcSEcCtD
Fulvestrant—NR1H4—PPARA activates gene expression—EP300—systemic lupus erythematosus	0.000423	0.00205	CbGpPWpGaD
Fulvestrant—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000422	0.00115	CcSEcCtD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000422	0.00205	CbGpPWpGaD
Fulvestrant—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000422	0.00115	CcSEcCtD
Fulvestrant—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000422	0.00115	CcSEcCtD
Fulvestrant—Vertigo—Prednisone—systemic lupus erythematosus	0.000418	0.00114	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000417	0.00114	CcSEcCtD
Fulvestrant—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000416	0.00114	CcSEcCtD
Fulvestrant—Anorexia—Betamethasone—systemic lupus erythematosus	0.000416	0.00114	CcSEcCtD
Fulvestrant—Urticaria—Prednisolone—systemic lupus erythematosus	0.000415	0.00114	CcSEcCtD
Fulvestrant—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000414	0.00113	CcSEcCtD
Fulvestrant—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	0.000414	0.00201	CbGpPWpGaD
Fulvestrant—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000413	0.00113	CcSEcCtD
Fulvestrant—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000413	0.00113	CcSEcCtD
Fulvestrant—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000412	0.00113	CcSEcCtD
Fulvestrant—Pain—Triamcinolone—systemic lupus erythematosus	0.000411	0.00112	CcSEcCtD
Fulvestrant—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000406	0.00111	CcSEcCtD
Fulvestrant—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000405	0.00111	CcSEcCtD
Fulvestrant—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000405	0.00111	CcSEcCtD
Fulvestrant—ESRRA—Generic Transcription Pathway—VDR—systemic lupus erythematosus	0.000405	0.00197	CbGpPWpGaD
Fulvestrant—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000403	0.0011	CcSEcCtD
Fulvestrant—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000403	0.0011	CcSEcCtD
Fulvestrant—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000403	0.0011	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—CXCL12—systemic lupus erythematosus	0.000403	0.00196	CbGpPWpGaD
Fulvestrant—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000402	0.0011	CcSEcCtD
Fulvestrant—ESR1—FOXM1 transcription factor network—EP300—systemic lupus erythematosus	0.000401	0.00195	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000397	0.00109	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000397	0.00109	CcSEcCtD
Fulvestrant—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000396	0.00108	CcSEcCtD
Fulvestrant—Myalgia—Prednisone—systemic lupus erythematosus	0.000396	0.00108	CcSEcCtD
Fulvestrant—Arthralgia—Prednisone—systemic lupus erythematosus	0.000396	0.00108	CcSEcCtD
Fulvestrant—Anxiety—Prednisone—systemic lupus erythematosus	0.000395	0.00108	CcSEcCtD
Fulvestrant—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000394	0.00108	CcSEcCtD
Fulvestrant—Insomnia—Betamethasone—systemic lupus erythematosus	0.000394	0.00108	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000393	0.00108	CcSEcCtD
Fulvestrant—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000393	0.00191	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CCL2—systemic lupus erythematosus	0.000393	0.00191	CbGpPWpGaD
Fulvestrant—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000393	0.00107	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000392	0.00107	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	0.000392	0.0019	CbGpPWpGaD
Fulvestrant—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000392	0.00107	CcSEcCtD
Fulvestrant—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000392	0.00107	CcSEcCtD
Fulvestrant—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	0.00039	0.0019	CbGpPWpGaD
Fulvestrant—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000389	0.00106	CcSEcCtD
Fulvestrant—ESR1—FOXA1 transcription factor network—EP300—systemic lupus erythematosus	0.000386	0.00188	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000385	0.00105	CcSEcCtD
Fulvestrant—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000384	0.00105	CcSEcCtD
Fulvestrant—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000384	0.00105	CcSEcCtD
Fulvestrant—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000383	0.00105	CcSEcCtD
Fulvestrant—ESR1—ATF-2 transcription factor network—IFNG—systemic lupus erythematosus	0.000383	0.00186	CbGpPWpGaD
Fulvestrant—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000382	0.00104	CcSEcCtD
Fulvestrant—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000381	0.00104	CcSEcCtD
Fulvestrant—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.00038	0.00104	CcSEcCtD
Fulvestrant—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00038	0.00104	CcSEcCtD
Fulvestrant—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000379	0.00104	CcSEcCtD
Fulvestrant—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000379	0.00104	CcSEcCtD
Fulvestrant—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000379	0.00104	CcSEcCtD
Fulvestrant—Infection—Prednisone—systemic lupus erythematosus	0.000377	0.00103	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000376	0.00103	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000376	0.00103	CcSEcCtD
Fulvestrant—Back pain—Methotrexate—systemic lupus erythematosus	0.000376	0.00103	CcSEcCtD
Fulvestrant—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000376	0.00103	CcSEcCtD
Fulvestrant—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000376	0.00103	CcSEcCtD
Fulvestrant—Fatigue—Betamethasone—systemic lupus erythematosus	0.000376	0.00103	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	0.000376	0.00183	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NAT2—systemic lupus erythematosus	0.000374	0.00182	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.000373	0.00181	CbGpPWpGaD
Fulvestrant—Pain—Betamethasone—systemic lupus erythematosus	0.000373	0.00102	CcSEcCtD
Fulvestrant—Pain—Dexamethasone—systemic lupus erythematosus	0.000373	0.00102	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	0.000373	0.00181	CbGpPWpGaD
Fulvestrant—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000372	0.00102	CcSEcCtD
Fulvestrant—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.00037	0.00101	CcSEcCtD
Fulvestrant—Skin disorder—Prednisone—systemic lupus erythematosus	0.000369	0.00101	CcSEcCtD
Fulvestrant—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000367	0.001	CcSEcCtD
Fulvestrant—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000366	0.001	CcSEcCtD
Fulvestrant—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000365	0.000998	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—PRL—systemic lupus erythematosus	0.000365	0.00177	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	0.000365	0.00177	CbGpPWpGaD
Fulvestrant—Rash—Cyclosporine—systemic lupus erythematosus	0.000362	0.00099	CcSEcCtD
Fulvestrant—Anorexia—Prednisone—systemic lupus erythematosus	0.000362	0.00099	CcSEcCtD
Fulvestrant—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000362	0.000989	CcSEcCtD
Fulvestrant—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000361	0.000987	CcSEcCtD
Fulvestrant—Headache—Cyclosporine—systemic lupus erythematosus	0.00036	0.000984	CcSEcCtD
Fulvestrant—Anaemia—Methotrexate—systemic lupus erythematosus	0.000359	0.000983	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000357	0.000975	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000357	0.000975	CcSEcCtD
Fulvestrant—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000356	0.000974	CcSEcCtD
Fulvestrant—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000354	0.000968	CcSEcCtD
Fulvestrant—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000353	0.000966	CcSEcCtD
Fulvestrant—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000353	0.000966	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	0.000353	0.00172	CbGpPWpGaD
Fulvestrant—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000353	0.000965	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—HIST2H2AC—systemic lupus erythematosus	0.000351	0.00171	CbGpPWpGaD
Fulvestrant—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000351	0.00096	CcSEcCtD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.00035	0.0017	CbGpPWpGaD
Fulvestrant—Vertigo—Methotrexate—systemic lupus erythematosus	0.000349	0.000955	CcSEcCtD
Fulvestrant—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000349	0.000955	CcSEcCtD
Fulvestrant—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000348	0.000952	CcSEcCtD
Fulvestrant—Urticaria—Betamethasone—systemic lupus erythematosus	0.000346	0.000947	CcSEcCtD
Fulvestrant—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000346	0.000947	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000346	0.000946	CcSEcCtD
Fulvestrant—Dizziness—Prednisolone—systemic lupus erythematosus	0.000346	0.000945	CcSEcCtD
Fulvestrant—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000345	0.000943	CcSEcCtD
Fulvestrant—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000345	0.000942	CcSEcCtD
Fulvestrant—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000345	0.000942	CcSEcCtD
Fulvestrant—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000345	0.000942	CcSEcCtD
Fulvestrant—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000345	0.000942	CcSEcCtD
Fulvestrant—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000344	0.000941	CcSEcCtD
Fulvestrant—Insomnia—Prednisone—systemic lupus erythematosus	0.000343	0.000939	CcSEcCtD
Fulvestrant—ESR1—Regulation of Telomerase—IFNG—systemic lupus erythematosus	0.000342	0.00166	CbGpPWpGaD
Fulvestrant—Nausea—Cyclosporine—systemic lupus erythematosus	0.000341	0.000933	CcSEcCtD
Fulvestrant—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000341	0.000932	CcSEcCtD
Fulvestrant—Pruritus—Triamcinolone—systemic lupus erythematosus	0.00034	0.00093	CcSEcCtD
Fulvestrant—Cough—Methotrexate—systemic lupus erythematosus	0.000339	0.000928	CcSEcCtD
Fulvestrant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000339	0.00165	CbGpPWpGaD
Fulvestrant—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000339	0.000928	CcSEcCtD
Fulvestrant—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000338	0.000923	CcSEcCtD
Fulvestrant—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000334	0.000914	CcSEcCtD
Fulvestrant—ESR1—AP-1 transcription factor network—IFNG—systemic lupus erythematosus	0.000334	0.00162	CbGpPWpGaD
Fulvestrant—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000333	0.00091	CcSEcCtD
Fulvestrant—ESR1—Leptin signaling pathway—NOS3—systemic lupus erythematosus	0.000331	0.00161	CbGpPWpGaD
Fulvestrant—Chest pain—Methotrexate—systemic lupus erythematosus	0.000331	0.000905	CcSEcCtD
Fulvestrant—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000331	0.000905	CcSEcCtD
Fulvestrant—Myalgia—Methotrexate—systemic lupus erythematosus	0.000331	0.000905	CcSEcCtD
Fulvestrant—Decreased appetite—Prednisone—systemic lupus erythematosus	0.00033	0.000903	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—TNFSF13—systemic lupus erythematosus	0.00033	0.0016	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	0.00033	0.0016	CbGpPWpGaD
Fulvestrant—Rash—Prednisolone—systemic lupus erythematosus	0.00033	0.000901	CcSEcCtD
Fulvestrant—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000329	0.0009	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000329	0.000899	CcSEcCtD
Fulvestrant—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000328	0.000897	CcSEcCtD
Fulvestrant—Fatigue—Prednisone—systemic lupus erythematosus	0.000327	0.000895	CcSEcCtD
Fulvestrant—Headache—Prednisolone—systemic lupus erythematosus	0.000327	0.000895	CcSEcCtD
Fulvestrant—NR1H4—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	0.000327	0.00159	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.000325	0.00158	CbGpPWpGaD
Fulvestrant—Constipation—Prednisone—systemic lupus erythematosus	0.000325	0.000888	CcSEcCtD
Fulvestrant—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000325	0.000887	CcSEcCtD
Fulvestrant—Rash—Hydrocortisone—systemic lupus erythematosus	0.000322	0.00088	CcSEcCtD
Fulvestrant—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000322	0.000879	CcSEcCtD
Fulvestrant—Headache—Hydrocortisone—systemic lupus erythematosus	0.00032	0.000874	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—SNRPB—systemic lupus erythematosus	0.00032	0.00155	CbGpPWpGaD
Fulvestrant—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000318	0.000869	CcSEcCtD
Fulvestrant—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000317	0.000867	CcSEcCtD
Fulvestrant—Infection—Methotrexate—systemic lupus erythematosus	0.000315	0.000862	CcSEcCtD
Fulvestrant—Asthenia—Betamethasone—systemic lupus erythematosus	0.000313	0.000855	CcSEcCtD
Fulvestrant—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000313	0.000855	CcSEcCtD
Fulvestrant—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000311	0.000851	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000311	0.000849	CcSEcCtD
Fulvestrant—ESR1—Regulation of Telomerase—CDKN1B—systemic lupus erythematosus	0.000311	0.00151	CbGpPWpGaD
Fulvestrant—Nausea—Prednisolone—systemic lupus erythematosus	0.00031	0.000849	CcSEcCtD
Fulvestrant—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000309	0.000843	CcSEcCtD
Fulvestrant—Pruritus—Betamethasone—systemic lupus erythematosus	0.000309	0.000843	CcSEcCtD
Fulvestrant—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000308	0.000843	CcSEcCtD
Fulvestrant—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000307	0.000839	CcSEcCtD
Fulvestrant—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000306	0.000835	CcSEcCtD
Fulvestrant—ESR1—ATF-2 transcription factor network—EP300—systemic lupus erythematosus	0.000305	0.00149	CbGpPWpGaD
Fulvestrant—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000305	0.000834	CcSEcCtD
Fulvestrant—ESR1—Regulation of Telomerase—IL2—systemic lupus erythematosus	0.000304	0.00148	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CDKN1B—systemic lupus erythematosus	0.000303	0.00148	CbGpPWpGaD
Fulvestrant—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000303	0.000829	CcSEcCtD
Fulvestrant—Rash—Triamcinolone—systemic lupus erythematosus	0.000303	0.000828	CcSEcCtD
Fulvestrant—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000303	0.000828	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	0.000303	0.00147	CbGpPWpGaD
Fulvestrant—Anorexia—Methotrexate—systemic lupus erythematosus	0.000303	0.000827	CcSEcCtD
Fulvestrant—Rash—Methylprednisolone—systemic lupus erythematosus	0.000302	0.000827	CcSEcCtD
Fulvestrant—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000302	0.000826	CcSEcCtD
Fulvestrant—Urticaria—Prednisone—systemic lupus erythematosus	0.000302	0.000825	CcSEcCtD
Fulvestrant—Headache—Triamcinolone—systemic lupus erythematosus	0.000301	0.000823	CcSEcCtD
Fulvestrant—Headache—Methylprednisolone—systemic lupus erythematosus	0.0003	0.000821	CcSEcCtD
Fulvestrant—Body temperature increased—Prednisone—systemic lupus erythematosus	0.0003	0.000821	CcSEcCtD
Fulvestrant—Abdominal pain—Prednisone—systemic lupus erythematosus	0.0003	0.000821	CcSEcCtD
Fulvestrant—ESRRA—Metabolism—NAT2—systemic lupus erythematosus	0.000299	0.00145	CbGpPWpGaD
Fulvestrant—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000298	0.000816	CcSEcCtD
Fulvestrant—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000298	0.000816	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	0.000297	0.00144	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL2—systemic lupus erythematosus	0.000297	0.00144	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—VDR—systemic lupus erythematosus	0.000296	0.00144	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	0.000293	0.00143	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—JAK1—systemic lupus erythematosus	0.000292	0.00142	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000289	0.000791	CcSEcCtD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	0.000289	0.0014	CbGpPWpGaD
Fulvestrant—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000288	0.000788	CcSEcCtD
Fulvestrant—Dizziness—Betamethasone—systemic lupus erythematosus	0.000288	0.000788	CcSEcCtD
Fulvestrant—ESR2—Gene Expression—TNFSF13—systemic lupus erythematosus	0.000287	0.0014	CbGpPWpGaD
Fulvestrant—Insomnia—Methotrexate—systemic lupus erythematosus	0.000287	0.000785	CcSEcCtD
Fulvestrant—ESR1—Validated nuclear estrogen receptor alpha network—EP300—systemic lupus erythematosus	0.000286	0.00139	CbGpPWpGaD
Fulvestrant—Nausea—Triamcinolone—systemic lupus erythematosus	0.000285	0.00078	CcSEcCtD
Fulvestrant—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	0.000285	0.00139	CbGpPWpGaD
Fulvestrant—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000285	0.000779	CcSEcCtD
Fulvestrant—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000285	0.000779	CcSEcCtD
Fulvestrant—ESR2—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	0.000285	0.00138	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	0.000285	0.00138	CbGpPWpGaD
Fulvestrant—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000283	0.000774	CcSEcCtD
Fulvestrant—ESRRA—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	0.000282	0.00137	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—MMP9—systemic lupus erythematosus	0.000281	0.00137	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.00028	0.000765	CcSEcCtD
Fulvestrant—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000279	0.000764	CcSEcCtD
Fulvestrant—ESR2—Gene Expression—SNRPB—systemic lupus erythematosus	0.000278	0.00135	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	0.000278	0.00135	CbGpPWpGaD
Fulvestrant—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000277	0.000758	CcSEcCtD
Fulvestrant—Vomiting—Betamethasone—systemic lupus erythematosus	0.000277	0.000758	CcSEcCtD
Fulvestrant—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000276	0.000754	CcSEcCtD
Fulvestrant—Rash—Dexamethasone—systemic lupus erythematosus	0.000275	0.000752	CcSEcCtD
Fulvestrant—Rash—Betamethasone—systemic lupus erythematosus	0.000275	0.000752	CcSEcCtD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	0.000275	0.00134	CbGpPWpGaD
Fulvestrant—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000275	0.000751	CcSEcCtD
Fulvestrant—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000275	0.000751	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000274	0.000749	CcSEcCtD
Fulvestrant—Fatigue—Methotrexate—systemic lupus erythematosus	0.000274	0.000748	CcSEcCtD
Fulvestrant—Headache—Betamethasone—systemic lupus erythematosus	0.000273	0.000747	CcSEcCtD
Fulvestrant—Headache—Dexamethasone—systemic lupus erythematosus	0.000273	0.000747	CcSEcCtD
Fulvestrant—Asthenia—Prednisone—systemic lupus erythematosus	0.000272	0.000745	CcSEcCtD
Fulvestrant—Pain—Methotrexate—systemic lupus erythematosus	0.000271	0.000742	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	0.00027	0.00131	CbGpPWpGaD
Fulvestrant—Pruritus—Prednisone—systemic lupus erythematosus	0.000269	0.000735	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	0.000267	0.0013	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	0.000266	0.0013	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—EP300—systemic lupus erythematosus	0.000266	0.0013	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	0.000264	0.00128	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000261	0.00127	CbGpPWpGaD
Fulvestrant—Diarrhoea—Prednisone—systemic lupus erythematosus	0.00026	0.00071	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.00026	0.00071	CcSEcCtD
Fulvestrant—Nausea—Betamethasone—systemic lupus erythematosus	0.000259	0.000708	CcSEcCtD
Fulvestrant—Nausea—Dexamethasone—systemic lupus erythematosus	0.000259	0.000708	CcSEcCtD
Fulvestrant—ESR2—Generic Transcription Pathway—VDR—systemic lupus erythematosus	0.000258	0.00125	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—HIST2H2AC—systemic lupus erythematosus	0.000257	0.00125	CbGpPWpGaD
Fulvestrant—Urticaria—Methotrexate—systemic lupus erythematosus	0.000252	0.000689	CcSEcCtD
Fulvestrant—Dizziness—Prednisone—systemic lupus erythematosus	0.000251	0.000687	CcSEcCtD
Fulvestrant—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000251	0.000686	CcSEcCtD
Fulvestrant—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000251	0.000686	CcSEcCtD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	0.000249	0.00121	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	0.000249	0.00121	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—JUNB—systemic lupus erythematosus	0.000246	0.00119	CbGpPWpGaD
Fulvestrant—Vomiting—Prednisone—systemic lupus erythematosus	0.000241	0.00066	CcSEcCtD
Fulvestrant—Rash—Prednisone—systemic lupus erythematosus	0.000239	0.000655	CcSEcCtD
Fulvestrant—Dermatitis—Prednisone—systemic lupus erythematosus	0.000239	0.000654	CcSEcCtD
Fulvestrant—Headache—Prednisone—systemic lupus erythematosus	0.000238	0.00065	CcSEcCtD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000238	0.00116	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	0.000237	0.00115	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000237	0.00115	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	0.000237	0.00115	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—TGFB1—systemic lupus erythematosus	0.000237	0.00115	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	0.000237	0.00115	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	0.000237	0.00115	CbGpPWpGaD
Fulvestrant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000237	0.00115	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000234	0.000639	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	0.000234	0.00114	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	0.000232	0.00113	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TGFB1—systemic lupus erythematosus	0.000232	0.00113	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	0.000228	0.00111	CbGpPWpGaD
Fulvestrant—Asthenia—Methotrexate—systemic lupus erythematosus	0.000228	0.000623	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—CD80—systemic lupus erythematosus	0.000227	0.00111	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	0.000226	0.0011	CbGpPWpGaD
Fulvestrant—Nausea—Prednisone—systemic lupus erythematosus	0.000226	0.000617	CcSEcCtD
Fulvestrant—Pruritus—Methotrexate—systemic lupus erythematosus	0.000225	0.000614	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	0.000224	0.00109	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—HIST2H2AC—systemic lupus erythematosus	0.000224	0.00109	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NAT2—systemic lupus erythematosus	0.000218	0.00106	CbGpPWpGaD
Fulvestrant—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000217	0.000594	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—RXRA—systemic lupus erythematosus	0.000215	0.00105	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MTA2—systemic lupus erythematosus	0.000215	0.00104	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	0.000213	0.00104	CbGpPWpGaD
Fulvestrant—Dizziness—Methotrexate—systemic lupus erythematosus	0.00021	0.000574	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—RXRA—systemic lupus erythematosus	0.000209	0.00102	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	0.000206	0.001	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	0.000206	0.001	CbGpPWpGaD
Fulvestrant—Vomiting—Methotrexate—systemic lupus erythematosus	0.000202	0.000552	CcSEcCtD
Fulvestrant—Rash—Methotrexate—systemic lupus erythematosus	0.0002	0.000547	CcSEcCtD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL6—systemic lupus erythematosus	0.0002	0.000973	CbGpPWpGaD
Fulvestrant—Dermatitis—Methotrexate—systemic lupus erythematosus	0.0002	0.000547	CcSEcCtD
Fulvestrant—Headache—Methotrexate—systemic lupus erythematosus	0.000199	0.000544	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—VDR—systemic lupus erythematosus	0.000195	0.000948	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	0.000194	0.000944	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000193	0.000937	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	0.000192	0.000934	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—TYK2—systemic lupus erythematosus	0.000192	0.000933	CbGpPWpGaD
Fulvestrant—Nausea—Methotrexate—systemic lupus erythematosus	0.000189	0.000515	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	0.000187	0.000908	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	0.000183	0.000888	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	0.000182	0.000886	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.00018	0.000876	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	0.00018	0.000874	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—JUNB—systemic lupus erythematosus	0.00018	0.000873	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NR3C1—systemic lupus erythematosus	0.000176	0.000853	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL6—systemic lupus erythematosus	0.000175	0.000848	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	0.000173	0.000843	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—RXRA—systemic lupus erythematosus	0.000167	0.000814	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.000164	0.000796	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—CDKN1B—systemic lupus erythematosus	0.000163	0.000793	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—RXRA—systemic lupus erythematosus	0.000157	0.000765	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—JUNB—systemic lupus erythematosus	0.000156	0.00076	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	0.000156	0.000758	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	0.000155	0.000755	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—CDKN1A—systemic lupus erythematosus	0.000151	0.000732	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	0.000148	0.000721	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—TNFSF13—systemic lupus erythematosus	0.000145	0.000705	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	0.000144	0.0007	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	0.000144	0.000698	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	0.000143	0.000698	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—VDR—systemic lupus erythematosus	0.000143	0.000693	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SNRPB—systemic lupus erythematosus	0.00014	0.000683	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—RXRA—systemic lupus erythematosus	0.000137	0.000666	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	0.000136	0.000663	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	0.000136	0.000663	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—PPARG—systemic lupus erythematosus	0.000136	0.000661	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	0.000136	0.000661	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PPARG—systemic lupus erythematosus	0.000132	0.000643	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—VDR—systemic lupus erythematosus	0.00013	0.000632	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NR3C1—systemic lupus erythematosus	0.000128	0.000624	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	0.000125	0.00061	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—VDR—systemic lupus erythematosus	0.000124	0.000603	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—RXRA—systemic lupus erythematosus	0.000122	0.000595	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	0.000119	0.00058	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ALB—systemic lupus erythematosus	0.000119	0.000578	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	0.000117	0.000569	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NOS3—systemic lupus erythematosus	0.000114	0.000553	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	0.000113	0.000552	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	0.000113	0.00055	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HIST2H2AC—systemic lupus erythematosus	0.000113	0.000548	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NR3C1—systemic lupus erythematosus	0.000112	0.000543	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARG—systemic lupus erythematosus	0.000106	0.000514	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—systemic lupus erythematosus	0.000104	0.000506	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	0.000104	0.000504	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	0.000102	0.000498	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPARG—systemic lupus erythematosus	9.93e-05	0.000483	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	9.69e-05	0.000471	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ALB—systemic lupus erythematosus	9.51e-05	0.000462	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—systemic lupus erythematosus	9.38e-05	0.000456	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—NOS3—systemic lupus erythematosus	9.09e-05	0.000442	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	9.06e-05	0.000441	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARG—systemic lupus erythematosus	8.65e-05	0.000421	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—EP300—systemic lupus erythematosus	8.65e-05	0.000421	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—systemic lupus erythematosus	8.32e-05	0.000404	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TLR9—systemic lupus erythematosus	8.01e-05	0.00039	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—JUNB—systemic lupus erythematosus	7.88e-05	0.000383	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	7.76e-05	0.000377	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARG—systemic lupus erythematosus	7.73e-05	0.000376	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	7.33e-05	0.000356	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CSK—systemic lupus erythematosus	7.14e-05	0.000347	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—systemic lupus erythematosus	6.95e-05	0.000338	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—EP300—systemic lupus erythematosus	6.92e-05	0.000336	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RXRA—systemic lupus erythematosus	6.91e-05	0.000336	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NOS3—systemic lupus erythematosus	6.64e-05	0.000323	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NCF2—systemic lupus erythematosus	6.53e-05	0.000318	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LYN—systemic lupus erythematosus	6.49e-05	0.000316	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.37e-05	0.00031	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—VDR—systemic lupus erythematosus	6.26e-05	0.000304	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—systemic lupus erythematosus	6.08e-05	0.000295	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NR3C1—systemic lupus erythematosus	5.63e-05	0.000274	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.22e-05	0.000254	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JUNB—systemic lupus erythematosus	5.13e-05	0.000249	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—EP300—systemic lupus erythematosus	5.05e-05	0.000246	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.87e-05	0.000237	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRL—systemic lupus erythematosus	4.72e-05	0.00023	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARG—systemic lupus erythematosus	4.36e-05	0.000212	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JAK1—systemic lupus erythematosus	3.78e-05	0.000184	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR5—systemic lupus erythematosus	3.58e-05	0.000174	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.53e-05	0.000172	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—C3—systemic lupus erythematosus	3.5e-05	0.00017	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.12e-05	0.000152	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—F2—systemic lupus erythematosus	3.07e-05	0.000149	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CD80—systemic lupus erythematosus	2.94e-05	0.000143	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.74e-05	0.000133	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.49e-05	0.000121	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOS3—systemic lupus erythematosus	2.44e-05	0.000119	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.11e-05	0.000103	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2—systemic lupus erythematosus	2.07e-05	0.000101	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.96e-05	9.52e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.95e-05	9.48e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EP300—systemic lupus erythematosus	1.86e-05	9.02e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.76e-05	8.55e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.75e-05	8.51e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.61e-05	7.84e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—systemic lupus erythematosus	1.22e-05	5.91e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.11e-05	5.38e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	9.94e-06	4.83e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	9.51e-06	4.62e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	8.7e-06	4.23e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	7.23e-06	3.52e-05	CbGpPWpGaD
